Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Oct
30
2015
 Estoppel in Context of Inter Partes Review Proceedings McDermott Will & Emery
Oct
29
2015
 Marijuana in the Workplace: The Growing Conflict Between Drug and Employment Laws Epstein Becker & Green, P.C.
Oct
29
2015
 Court Orders Re-Trial of AseraCare Falsity Phase Based on Jury Instruction Errors McDermott Will & Emery
Oct
28
2015
 Inferior Vena Cava (IVC) Claims Are on the Rise Stark & Stark
Oct
28
2015
 Brazil: Federal District Court in Rio de Janeiro Declares AstraZeneca’s Patent Covering Fosladex Invalid Michael Best & Friedrich LLP
Oct
27
2015
 Recent Reports Claim Improvements in FDA’s Review of Medical Device Submissions Covington & Burling LLP
Oct
26
2015
 Meaty Issue: Do Red and Processed Meats Cause Cancer? ArentFox Schiff LLP
Oct
26
2015
 President Announces Efforts to Target Prescription Drug Abuse and Heroin Epidemic Jackson Lewis P.C.
Oct
23
2015
 FDA’s Office of Planning Issues Report on Review Process for Combination Products Covington & Burling LLP
Oct
23
2015
 Australian Patent Office Proposes “Coding Only” Sequence Ban
Oct
22
2015
 Medical Cannabis in Illinois: What Employers Need to Know Much Shelist, P.C.
Oct
22
2015
 FTC Takes No Action Re: Use of “Diet” in Zero Calorie Soft Drinks; FDA Still Reviewing Morgan, Lewis & Bockius LLP
Oct
20
2015
 D.C. Federal Court Rejects HHS Interpretation of 340B Program’s Orphan Drug Rule McDermott Will & Emery
Oct
20
2015
 The Federal Circuit Declines To Revisit Its Decision That The Biosimilars Patent Dance Is Optional – Next Stop, Supreme Court? Squire Patton Boggs (US) LLP
Oct
20
2015
 D.C. District Court Vacates HRSA’s Interpretative Rule on Orphan Drugs Epstein Becker & Green, P.C.
Oct
19
2015
 No Rehearing Of Biosimilar Patent Dance Decision Foley & Lardner LLP
Oct
19
2015
 D.C. Court Strikes Down 340B Orphan Drug Rule Again: Will This Impact the “Mega Guidance”? Foley & Lardner LLP
Oct
19
2015
 House To Vote On ACA Repeal Provisions; HHS Projects 2016 ACA Marketplace Enrollment; HRSA’s 340B Orphan Drug Policy Struck Down Again Squire Patton Boggs (US) LLP
Oct
19
2015
 It’s Status Quo for Now: Federal Circuit Denies Petition for Rehearing En Banc in Amgen v. Sandoz Michael Best & Friedrich LLP
Oct
16
2015
 China's New Food Safety Law Became Effective Oct. 1: Are You in Compliance? Keller and Heckman LLP
Oct
16
2015
 China's New Food Safety Law is in Effect Keller and Heckman LLP
Oct
15
2015
 FDA to Host First Public Meeting on Biotech Regulation Overhaul Mintz
Oct
13
2015
 PTAB Institutes Kyle Bass Lialda Patent IPR Foley & Lardner LLP
Oct
12
2015
 Next Rx: New Medicare Part D Initiative Advances Role of Medication Management in Reform Sheppard, Mullin, Richter & Hampton LLP
Oct
12
2015
 FDA Releases First Wholesaler and 3PL Facility Licensure Data to the Public Mintz
Oct
9
2015
 Vermont GMO Battle Continues in Second Circuit Armstrong Teasdale
Oct
8
2015
 Medical Cannabis in Illinois: What Health Care Providers and Organizations Need to Know Much Shelist, P.C.
Oct
8
2015
 Proposed 340B Guidance: Who is the Biggest Loser? Mintz
Displaying 10053 - 10080 of 12256
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters